Cure My Disease

Don't miss your cure!

 Log in / Sign up

Green dye could help surgeons spot hidden cancer in kids

NCT ID NCT07054944

Recruiting now Diagnosis Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a green dye called indocyanine green (ICG) can help surgeons find sentinel lymph nodes—the first nodes where cancer might spread—in children with solid tumors. Ten children under 18 will get the dye injected during surgery, and doctors will check if it lights up the right nodes. The goal is to see if this method is safe and works well, which could lead to more precise surgery and fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Indocyanine Green (ICG) dye
What this could lead to
If successful, this technique could make lymph node removal more precise and less invasive for children with solid tumors, potentially reducing side effects.
What could go wrong
This is a very small early study with only 10 children, so results may not apply to everyone. The dye may not always reach the right nodes, and there is a small risk of allergic reaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

childhood neoplasm germ cell tumor neoplasm Neoplasms, Germ Cell and Embryonal rhabdomyosarcoma sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GERM CELL TUMOR PEDIATRIC SOLID TUMORS RHABDOMYOSARCOMA SARCOMA

Contacts and locations

Locations

  • University of Rochester Medical Center

    RECRUITING

    Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.